Results(4493)
Retrospective and prospective observational study on the systemic outcomes of lysosomal storage diseases with skeletal involvement in their natural history or during standard of care treatment
Italy
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000746
First published:
11/11/2025
Study
Planned
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the BKEMV™ Risk Evaluation and Mitigation Strategy (REMS) (20240216)
United States
EU PAS number:
EUPAS1000000367
First published:
11/11/2025
Study
Planned
Comparative effectiveness and safety in patients with prostate cancer who received radical prostatectomy vs. radiotherapy: target trial emulation
Estonia
Germany
United Kingdom
EU PAS number:
EUPAS1000000808
First published:
11/11/2025
Study
Ongoing
Health Care Professionals and Patients' perceptions, behaviors, perspectives, and barriers on the implementation of the new (2018) Risk Minimization Measures (RMMs) of valproate in Europe: A Qualitative Non-Interventional Post Authorization Safety Study (PASS) (EPM0076)
France
Germany
Poland
Spain
Sweden
EU PAS number:
EUPAS1000000693
First published:
11/11/2025
Study
Planned
An Active Surveillance Study to Monitor the Safety of Abrocitinib Among Real-World Patients with Atopic Dermatitis (AD) in the European Union (EU) (B7451084)
Denmark
France
Sweden
EU PAS number:
EUPAS1000000282
First published:
11/11/2025
Study
Ongoing
Studies on tissue specific carcinogenicity and on metabolism of N-nitrosamines (SC05 to FWC EMA/2020/46/TDA/L1.02 – ROC38))
Germany
EU PAS number:
EUPAS1000000819
First published:
11/11/2025
Study
Planned
The Valencia Health System Integrated Database
First published:
11/11/2025
Spain
Data source
Human
Hospital outpatient visit records
Other
Primary care medical records
Registration with healthcare system
EFEMERIS
First published:
11/11/2025
France
Data source
Human
Administrative healthcare records (e.g., claims)
Other
Pharmacy dispensing records
DARWIN EU® -Drug utilisation of salbutamol products for inhalation and therapeutic alternative inhalation products
Croatia
Denmark
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000403
First published:
11/11/2025
Study
Finalised
Semaglutide in patients with heart failure with reduced ejection fraction: safety and effectiveness – a target trial emulation
France
Netherlands
Portugal
Sweden
EU PAS number:
EUPAS1000000809
First published:
10/11/2025
Study
Planned
Pregnancy and Neonatal Outcomes following Prenatal Exposure to Cabotegravir: Data from The Antiretroviral Pregnancy Registry (APR) (215325)
Czechia
France
EU PAS number:
EUPAS45685
First published:
10/11/2025
Study
Ongoing
Assessing the impact of remission at 12-months post-initiation of biologic therapy on long-term clinical outcomes of patients with severe asthma (SPOTLIGHT)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
Greece
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000789
First published:
10/11/2025
Study
Ongoing
Incidence of selected adverse events in a population-based Danish cohort with atopic dermatitis treated with conventional systemic therapies: a matched case-cohort study.
Denmark
EU PAS number:
EUPAS1000000628
First published:
10/11/2025
Study
Planned
DARWIN EU® - RR DUS GLP1 RA
Croatia
Finland
Germany
Spain
Sweden
EU PAS number:
EUPAS1000000828
First published:
10/11/2025
Study
Planned
DARWIN EU® - Treatment characterisation and post-diagnosis outcomes in Alzheimer’s disease
Croatia
Denmark
Germany
Netherlands
EU PAS number:
EUPAS1000000827
First published:
10/11/2025
Study
Planned
DARWIN EU® - Alzheimer’s Disease: Incidence, Prevalence, and Individuals' Characteristics
Denmark
Germany
Netherlands
United Kingdom
EU PAS number:
EUPAS1000000826
First published:
10/11/2025
Study
Ongoing
DARWIN EU® - Capturing suicidality and depression related variables in databases
Denmark
Estonia
Finland
France
Germany
Greece
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000825
First published:
10/11/2025
Study
Planned
DARWIN EU® - Enhanced Preparedness of the DARWIN EU Network for regulatory questions in oncology – DARWIN OncoNet
Croatia
Denmark
Estonia
Finland
France
Greece
Hungary
Italy
Netherlands
Norway
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000824
First published:
10/11/2025
Study
Planned
DARWIN EU® - DUS Immunoglobulins
Denmark
France
Germany
United Kingdom
EU PAS number:
EUPAS1000000823
First published:
10/11/2025
Study
Planned
DARWIN EU® - Neonatal seizures: Incidence, prevalence, patient characterisation, and treatments in European countries
Finland
France
Hungary
Norway
EU PAS number:
EUPAS1000000822
First published:
10/11/2025
Study
Ongoing
DARWIN EU® - Treatment patterns in postmenopausal women
Denmark
Germany
Spain
United Kingdom
EU PAS number:
EUPAS1000000821
First published:
10/11/2025
Study
Ongoing
DARWIN EU® - Capturing obesity in DARWIN EU
Belgium
Croatia
Denmark
France
Germany
Greece
Netherlands
Portugal
Spain
EU PAS number:
EUPAS1000000820
First published:
10/11/2025
Study
Planned
DARWIN EU® - Drug Utilisation Study on Antibiotics in the ‘Reserve’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
Denmark
France
Greece
Hungary
Italy
Portugal
Spain
EU PAS number:
EUPAS1000000664
First published:
10/11/2025
Study
Ongoing
DARWIN EU® - Drug utilisation study on antibiotics in the ‘Access’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
Croatia
Denmark
Finland
Germany
Netherlands
Spain
EU PAS number:
EUPAS1000000663
First published:
10/11/2025
Study
Ongoing
DARWIN EU® - Drug Utilisation Study on Antibiotics in the ‘Watch’ category of the WHO AWaRe classification of antibiotics for evaluation and monitoring of use
Croatia
Denmark
Finland
France
Germany
Hungary
Netherlands
Spain
EU PAS number:
EUPAS1000000665
First published:
10/11/2025
Study
Ongoing
DARWIN EU® – Incidence rates of venous thromboembolic events in patients with selected cancers
Belgium
Denmark
Estonia
Finland
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000440
First published:
10/11/2025
Study
Finalised
DARWIN EU® - Characterisation of systemic treatments for the management of ovarian cancer
Denmark
France
Netherlands
Norway
EU PAS number:
EUPAS1000000815
First published:
10/11/2025
Study
Ongoing
DARWIN EU® - Acute myeloid leukaemia: incidence, patient characteristics, treatments, and survival in the period 2015–2024
Croatia
Denmark
Finland
Germany
Netherlands
Norway
Spain
EU PAS number:
EUPAS1000000773
First published:
10/11/2025
Study
Ongoing
DARWIN EU® - Time to onset of thromboembolic events in adults with selected types of cancer
Belgium
Denmark
Estonia
Finland
Germany
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000814
First published:
10/11/2025
Study
Ongoing
DARWIN EU® – Drug Utilisation Study of terbinafine-containing products
Croatia
Denmark
Finland
Germany
Spain
United Kingdom
EU PAS number:
EUPAS1000000790
First published:
10/11/2025
Study
Ongoing
Pharmacoepidemiology and Pharmacovigilance Unit, Department of Pharmacy, Pharmacology and Health Technologies, Faculty of Pharmacy University of Lisbon (FFUL)
Portugal
First published:
07/11/2025
Institution
Educational Institution
ENCePP partner
DARWIN EU® - RR1 Drug Utilisation Study of prescription opioids
Belgium
Denmark
Estonia
France
Netherlands
Norway
Spain
EU PAS number:
EUPAS1000000479
First published:
07/11/2025
Study
Finalised
DARWIN EU® - RR2 Drug utilisation study of prescription opioids
Croatia
Finland
Germany
Hungary
Italy
Portugal
Sweden
EU PAS number:
EUPAS1000000615
First published:
07/11/2025
Study
Ongoing
Post-Authorization Safety Study to Assess the Effectiveness of the Newly Implemented Risk Minimization Measures for Topiramate: HCP and Patient Knowledge and Behavior Survey
France
Germany
Poland
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000806
First published:
06/11/2025
Study
Planned
Long-term, observational cohort study of adults with plaque psoriasis (PsO), who are new users of deucravacitinib, tumour necrosis factor inhibitor (TNFi) biologics, non-TNFi biologics, or non-biologic therapies in the real-world clinical setting
Denmark
Finland
France
Germany
Norway
Spain
EU PAS number:
EUPAS1000000659
First published:
06/11/2025
Study
Planned
Adenosine Deaminase Severe Combined Immunodeficiency (ADA-SCID) Registry for Patients Treated with Strimvelis (or GSK2696273) Gene Therapy: Long-Term Prospective, Non-Interventional Follow-up of Safety and Effectiveness (STRIM-003)
Italy
EU PAS number:
EUPAS15795
First published:
06/11/2025
Study
Ongoing
Acute effects of intravitreal aflibercept injections on intraocular pressure in vitrectomized and silicone-oil-filled eyes (NH_SiOP)
Hungary
EU PAS number:
EUPAS1000000811
First published:
06/11/2025
Study
Finalised
Pharmacoepidemiology and Drug Safety Research Group (PharmaSafe), University of Oslo
Norway
First published:
06/11/2025
Institution
Educational Institution
ENCePP partner
Patient outcomes and clinical characteristics of ATTR-CM patients treated with tafamidis: A single center experience in Turkey - Study ATTREAL
Türkiye
EU PAS number:
EUPAS1000000561
First published:
06/11/2025
Study
Ongoing
A post-authorisation safety study of ABRYSVO in immunocompromised, or renally or hepatically impaired adults aged 60 years and older in a real world setting in Europe and UK (C3671038)
France
Spain
United Kingdom
EU PAS number:
EUPAS1000000400
First published:
06/11/2025
Study
Ongoing